Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge.

[1]  E. Shalev,et al.  Correlation between estradiol and progesterone in cycles with luteal phase deficiency. , 1982, Fertility and sterility.

[2]  N. Faure,et al.  Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women. , 1982, Fertility and sterility.

[3]  R. Casper,et al.  Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility. , 1982, Fertility and sterility.

[4]  P. Robel,et al.  Clinical Investigation of the Menstrual Cycle. III. Clinical, Endometrial, and Endocrine Aspects of Luteal Defect**Supported by the Faculté de Médecine de Créteil. , 1981 .

[5]  D. Rabin,et al.  Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. , 1980, The Journal of clinical endocrinology and metabolism.

[6]  C. Bergquist,et al.  Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women. , 1980, Contraception.

[7]  F. Labrie,et al.  Luteolytic effect of intranasal administration of [D-Ser(TBU)6,DES-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in normal women. , 1979, Fertility and sterility.

[8]  R. Casper,et al.  Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle. , 1979, American journal of obstetrics and gynecology.

[9]  J. M. Marsh,et al.  Inhibition of human chorionic gonadotropin-induced progesterone synthesis by estradiol in isolated human luteal cells. , 1979, The Journal of clinical endocrinology and metabolism.

[10]  T. Kumasaka,et al.  Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women. , 1978, Fertility and sterility.

[11]  H. Taubert,et al.  The effect of D-ser (TBU)6-LH-RH-EA10 upon gonadotropin release in normally cyclic women. , 1977, The Journal of clinical endocrinology and metabolism.

[12]  E. Johansson.  Inhibition of the corpus luteum function in women taking large doses of diethylstilbestrol , 1973 .

[13]  L. Speroff,et al.  Estrogen-induced human luteolysis. , 1973, The Journal of clinical endocrinology and metabolism.

[14]  R. Rebar,et al.  Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle. , 1972, The Journal of clinical endocrinology and metabolism.

[15]  L. Wide,et al.  VARIATION IN LH AND FSH RESPONSE TO LH‐RELEASING HORMONE DURING THE MENSTRUAL CYCLE , 1972, The Journal of obstetrics and gynaecology of the British Commonwealth.

[16]  J. Knippenberg,et al.  Gonadotropin release during repeated administration of d-Leu6 des Gly10-LH-RH-EA at different stages of the menstrual cycle and in functional amenorrhea. , 1980, International journal of fertility.

[17]  F. Labrie,et al.  Possible luteolytic effects of luteinizing hormone-releasing hormone in normal women. , 1979, Fertility and sterility.

[18]  A. Haspels,et al.  Effect of postovulatory adminstration of a “morning-after” injection on corpus luteum function and endometrium , 1977 .